Number of the records: 1  

pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy

  1. 1.
    SYSNO ASEP0369686
    Document TypeP - Patent
    R&D Document TypeThe record was not marked in the RIV
    TitlepH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
    Author(s) Ulbrich, Karel (UMCH-V) RID
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Říhová, Blanka (MBU-M) RID
    Jelínková, Markéta (MBU-M)
    Kovář, Marek (MBU-M) RID, ORCID
    Year of issue2011
    Patent no. or utility model no. or industrial design no.US7919076
    Date of the patent acceptance05.04.2011
    Name of the patent ownerZentiva, k. s
    Languageeng - English
    CountryUS - United States
    Keywordscancerostatics ; polymer cojugates ; targeted therapy
    Subject RIVCC - Organic Chemistry
    CEZAV0Z40500505 - UMCH-V (2005-2011)
    AV0Z50200510 - MBU-M (2005-2011)
    AnnotationConjugates consisting of a polymeric carrier constituted by 30 to 3,000 monomer units linked to form a polymeric chain, composed of a) 60 to 99% of N-(2-hydroxypropyl)methacrylamide units, b) 1 to 25% of units of methacryloylated hydrazones of .alpha.-amino acids, .epsilon.-amino acids, aromatic amino acids or oligopeptides terminated with a molecule of an anthracycline cancerostatic, c) 0.5 to 15% of units of methacryloylated .alpha.-amino acids, .epsilon.-amino acids, aromatic amino acids or oligopeptides or their sodium salts.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.